Introduction {#sec1-1}
============

Liver resection is the only therapeutic treatment option for several neoplastic entities of the liver (Simmonds et al., 2006; Van Cutsem et al., 2006). It becomes the routine aspect of administering certain liver conditions such as primary liver malignancies and secondary ones. Five-year survival is insignificant in un-treated patients compared with around 30% in those receiving hepatic resection (Simmonds et al., 2006). However, Hepatic resection is still among some of the most complex operative interventions performed and is full of risk and complications.

The most significant agent determining postoperative morbidity and mortality is the capacity of the remnant liver to regenerate (Clavien et al., 2007). Clinical inquiries, following removal of up to 50% of functional liver, found that there was usually only a gentle and short-lived rise in serum bilirubin and depression of serum proteins indicating sustained briefness of hepatocellular function (Iwatsuki and Starzl, 1988) (Savage and Malt, 1991; Nagasue et al., 1987; Huguet et al., 1992; Yamanaka et al., 1993). While removing up to 75% of the liver was allowance in most patients. However, it would be advantageous to estimate the size of the liver vestige after partial hepatectomy to reduce chances of liver insufficiency.

Post hepatectomy liver failure (PHLF) remains one of the most severe complications of major liver resection, and occurs in up to 10% of cases (Paugam-Burtz et al., 2009; Ren et al., 2012). Several studies report a lower average of PHLF in East Asian countries (1-2%), but when present, PHLF represents a significant source of morbidity and mortality (Ren et al., 2012). The definition of PHLF has varied widely among groups making comparison of rates between studies challenging. Numerous definitions of PHLF are found in the literature, with variations by country and between hospitals within the same country (Eguchi et al., 2000).

In 2011, the International Study Group of Liver Surgery (ISGLS) proposed a standardized definition and graded the severity of PHLF. After evaluating more than 50 studies on PHLF after hepatic resection, the consensus conference committee realized PHLF as "a post-operatively acquired deterioration in the ability of the liver to maintain its synthetic, excretory, and detoxifying functions, which are characterized by an increased INR and concomitant hyperbilirubinemia on or after postoperative day 5" (Rahbari et al., 2011).

The comparison between liver function before, perioperative liver resection and the interplay of clinical factors that predispose to liver failure following anatomical/ non-anatomical or malignant/ nonmalignant hepatectomy is the topic of this review. We will examine a number of clinical situations, which might shed light on causes of liver failure following resection in patients admitted in Al-Assad University Hospital from 2009 to 2016.

Materials and Methods {#sec1-2}
=====================

All patients who underwent liver resection at Al-Assad University Hospital in Damascus, Syria between 1/1/2009 and 31/3/2016 were evaluated to be included in this study. Patients who were not resectable or had undergone Radio ablation were excluded.

The Research Ethics Committee, Faculty of Medicine, Damascus University had approved this retrospective study by its decision number 16-02-06.

A group of medical students supervised by working physicians in the same hospital collected data manually from patient's charts in Archive, Laboratory, and Pathology Departments.

Standard demographic and clinic pathologic data were obtained including: age, sex, pathology (malignant, non- malignant), history of smoking or alcohol use, days in intensive care unit (ICU) and days of hospitalization.

Laboratory values including: INR, ALT, AST, Total protein, ALB, Urea, Creatinine, total bilirubin, of all patients were taken at pre-surgery and perioperative time. Pre-surgery Lab values were obtained at the first day of administration. Perioperative period was defined as the first three days after surgery. Identical laboratory samples were drawn multiple times in the perioperative period, the worst value was used for the purpose of analysis.

Patients were divided into two categories {#sec2-1}
-----------------------------------------

patients who had an anatomic resection and those who had non-anatomic resection, and into malignant and non-malignant categories. Anatomic resections involve two or more hepatic segments as described by (Couinaud, 1957)whereas non-anatomic involves the resection of metastases with a rim of uninvolved tissue (Strasberg, 2005).

Specific Technique {#sec2-2}
------------------

On administration, all patients underwent exclusive examinations and the decision to give neoadjuvant chemotherapy was taken according to each case. Resections were made by the same surgical technique, and performed under low central venous pressure general anesthesia. Surgical team performed only open resections with Pringle Manoeuvre used at the discretion of the surgeon. Intraoperative Ultra sound was used and hepatic parenchyma was divided by Clamp-Crush technique or energy-assisted devices. The patient's condition after surgery was used to admit patients in the ICU or in the Surgical Department.

Analysis {#sec2-3}
--------

Statistical significance was defined as 2-tailed P\<0.05. Data analyses were performed using SPSS and the missing data were excluded from analysis. Categorical variables were presented as percentage. Continuous variables were presented as mean or median (Range)

Chi-Square test was used to compare categorical variables whereas T-test was used to compare continuous variables.

Results {#sec1-5}
=======

This study included 104 patients; 56 of them were female (53.8%) and 48 were male (46.2%). The mean age of the patients was 49.327 (range 9-74). There were 25 smokers (24%) and 7 alcoholic (6.7%) patients.

The median length of stay in the hospital was 11 days, while the median length of stay in the ICU was 3 days. Of 104 patients, 67 had anatomic resection (64.4%) and 37 had non-anatomic resection (35.6%). There were 71 patients submitted to hepatic resection for malignant tumors (68.3%) and 31 for non-malignant tumors (29.8%) 2 missing data.

Discussion {#sec1-6}
==========

The purpose of this study was to identify the early change of liver function after liver resection. The liver is a multi-function organ with synthetic and metabolic functions, therefore no single test can assist its functions (Wagener, 2013; Mizuguchi et al., 2014). After resection, it begins to regenerate within 3 days and reaches its original size by 6 months (Nagasue et al., 1987; Gove and Hughes, 1991). Thus, we analyzed routine postoperative clinical practice and biochemical blood tests related to liver function.

Anatomic liver resection selection criteria are still expanding (Jarnagin et al., 2002; Imamura et al., 2003) due to development in anesthetic and surgical techniques. However, liver functions and hepatic insufficiency are still of a significant concern.

Liver synthetic functions are assessed by protein and coagulation factors synthesis. The decrease in protein synthesis affects albumin. Nevertheless; albumin is not specific or sensitive enough to detect compromised function. Protein loss with ascites might decrease albumin levels; so this decrease does not cop with the decrease in synthetic function. The increase of the international normalized ratio (INR) may refer to decrease in the synthesis of coagulation factors (Wagener, 2013). Transaminases are intracellular and intramitochondrial enzymes so they represent the degree of acute hepatic injury but not impairments of function (Wagener, 2013). The total bilirubin indicates to glucuronidation pathways (phase II) of metabolic hepatic function but it may give misleading result about liver function because it is insensitive to ischemic injury (Wagener, 2013).

Post-operative hepatic insufficiency defined as total serum bilirubin of \>7 mg/dl and/or the formation of new ascites, while some studies find that PoD 3 bilirubin level of ≥3 mg/dl was the predictive measure for Post-operative hepatic insufficiency (Mullen et al., 2007; Etra et al., 2014). None of our patients developed a total serum bilirubin more than 6.02 even patients who died. Serum bilirubin and INR are also used as measures of liver function (Bismuth et al., 1983; Ettorre et al., 2001) and used in the score to predict liver sufficiency after liver resection (Child and Turcotte, 1964; Schindl et al., 2005). They are considered as early predictors of death from postoperative liver failure (Balzan et al., 2005; Mullen et al., 2007). This study revealed significant differences in serum bilirubin and INR as shown in [Table 1](#T1){ref-type="table"} but we found slight differences between them when we compared anatomic versus non anatomic resection and malignant versus nonmalignant resection.

###### 

Compare Liver Function Tests Between Pre-Surgery (PS) and Perioperative Period (PO)

               N    PS        PO        P Value
  ------------ ---- --------- --------- ---------
  INR          81   1.1299    1.4267    \<0.001
  TP           68   7.426     5.581     \<0.001
  ALB          67   4.204     3.242     \<0.001
  ALT          77   27.597    200.221   \<0.001
  AST          76   33.395    190.553   \<0.001
  ALP          62   243.21    157.097   \<0.001
  T-Bill       78   0.0611    0.136     \<0.001
  Urea         83   28.49     27.986    0.681
  Creatinine   83   0.8518    0.788     0.053
  Na           86   141.264   141.688   0.662
  K            86   4.384     4.1076    \<0.001
  Cl           71   103.461   107.137   \<0.001

This study revealed significant decrease in liver synthetic functions as serum bilirubin and INR values show in [Table 1](#T1){ref-type="table"}, this kind of surgery led to function deterioration after performing the operation despite of the type of resection ([Table 2](#T2){ref-type="table"}, [3](#T3 T4 T5){ref-type="table"}). However, serum bilirubin and INR After the surgery were not different significantly when we compared anatomic versus non anatomic resection and malignant versus nonmalignant resection.

###### 

Compare Liver Function Tests Between Pre-Surgery (PS) and Perioperative Period (PO) in Patients Underwent Anatomic Resection Only

               N    PS        PO        P Value
  ------------ ---- --------- --------- ---------
  INR          54   1.1472    1.4507    \<0.001
  TP           44   7.536     5.627     \<0.001
  ALB          43   4.184     3.291     \<0.001
  ALT          50   26.88     213.52    \<0.001
  AST          50   32.74     209.48    \<0.001
  ALP          41   277.951   170.073   \<0.001
  T-Bill       52   0.5977    1.1208    0.005
  Urea         53   27.862    28.302    0.787
  Creatinine   54   0.8341    0.7711    0.132
  Na           57   141.57    141.816   0.859
  K            57   4.3156    4.1346    0.037
  Cl           47   103.485   107.077   \<0.001

###### 

Compare Liver Function Tests between Pre-Surgery (PS) and Perioperative Period (PO) in Patients Underwent Non- Anatomic Resection Only

               N    PS        PO        P Value
  ------------ ---- --------- --------- ---------
  INR          27   1.0952    1.3785    \<0.001
  TP           24   7.225     5.496     \<0.001
  ALB          24   4.242     3.154     \<0.001
  ALT          27   28.926    175.593   \<0.001
  AST          26   34.654    154.154   \<0.001
  ALP          21   175.381   131.762   0.002
  T-Bill       26   0.4377    0.8842    0.028
  Urea         30   29.6      27.427    0.238
  Creatinine   29   0.8848    0.8193    0.234
  Na           29   140.662   141.438   0.429
  K            29   4.5183    4.0545    0.001
  Cl           24   103.413   107.254   0.001

###### 

Compare between Anatomic and Non-Anatomic Live Resection

                    N    anatomic   N    non-anatomic   P Value
  ----------------- ---- ---------- ---- -------------- ---------
  Hospitalization   67   12.925     37   12.541         0.832
  ICU day           64   2.469      33   2.394          0.801
  Sex                                                   
   (Female)         56   37         56   19             0.704
   (Male)           48   30         48   18             
  Age               67   49.791     37   48.486         0.667
  After-Surgery                                         
   INR              57   1.4511     29   1.3921         0.359
   TP               56   5.611      28   5.482          0.427
   ALB              56   3.264      27   3.148          0.232
   ALT              55   206.418    29   178.966        0.548
   AST              55   202.8      29   161.483        0.243
   ALP              48   171.396    24   136.208        0.178
   T-Bill           57   1.1491     27   0.8978         0.365
   Na               61   142.044    33   141.106        0.474
   K                61   4.1244     33   4.0539         0.553
   Cl               57   107.17     28   107.354        0.88
   Urea             59   28.22      33   27.752         0.852
   Creatinine       60   0.7605     31   0.8271         0.332

###### 

Compare between Patients Submitted to Hepatic Resection for Malignant and Non-Malignant Reasons

                    N    malignant   N    non-malignant   P Value
  ----------------- ---- ----------- ---- --------------- ---------
  Hospitalization   71   13.577      31   11.065          0.189
  ICU day           66   2.621       29   2.069           0.073
  Sex                                                     
   (Female)         55   32          55   23              0.007
   (Male)           47   39          47   8               
  Age               71   52.31       31   42.839          0.002
  After-Surgery                                           
   INR              61   1.4184      24   1.4542          0.599
   TP               62   5.561       21   5.595           0.849
   ALB              61   3.202       21   3.281           0.451
   ALT              59   236.475     24   89.5            0.002
   AST              59   222.644     24   101.125         0.001
   ALP              51   158.078     20   160.9           0.919
   T-Bill           59   1.049       24   1.0683          0.946
   Na               66   141.7       27   141.659         0.977
   K                66   4.1427      27   4.003           0.267
   Cl               60   106.978     24   107.675         0.585
   Urea             65   29.935      26   23.615          0.017
   Creatinine       63   0.8095      27   0.7226          0.225

Renal function is affected by liver function, acute or chronic liver failure, (Gines et al., 2003) the postoperative renal function and non-renal complications are well known (Armstrong et al., 2009). The levels of serum creatinine and urea in patients who had an uncomplicated hepatectomy remained stable in normal range with little variant depending on the vast of resection and little increase of urea (Reissfelder et al., 2011). In this study the serum creatinine and urea levels in patients decreased as showed in [Table 1](#T1){ref-type="table"}. There was no significant change for both serum creatinine and urea levels when we compared anatomic versus non anatomic resection or serum creatinine when we compared malignant versus nonmalignant resection. However change happened in urea when we compared malignant versus nonmalignant resection.

Liver resection led to significant increase in transaminases as shown in [Table 1](#T1){ref-type="table"}. However, the type of resection (anatomic or non-anatomic) didn't affect that increase significantly. On the other hand, resection for malignant reasons showed significant higher increase in transaminases than resection for non-malignant reasons.

Limited concerns are the relatively small sample size, but our hospital is the central and major hospital for liver resection in Syria. Secondly, no primary analysis of postoperative complications, survival, or outcome prediction was performed because most of patients have followed up in their cities and there is no central patient record database in Syria. In the end, we could not analyze future liver remnant because it is not routinely calculated. We just presented the result of liver function during hospital stay and further study beyond 6 months should be proceeded to evaluate the late result.

In conclusion, we found no significant statistic differences (P \> 0.05) although it vary significantly in clinical values, in anatomic versus non anatomic liver resection or liver resection for malignant versus benign lesions which indicate all patients after liver resection need the same level of caring. However, this result is for liver function during hospital stay and further study beyond 6 months should be proceeded to evaluate the late result.
